Skip navigation
  • 中文
  • English

DSpace CRIS

  • DSpace logo
  • Home
  • Organizations
  • Researchers
  • Research Outputs
  • Explore by
    • Organizations
    • Researchers
    • Research Outputs
  • Academic & Publications
  • Sign in
  • 中文
  • English
  1. NTU Scholars
  2. Research Outputs

Browsing by Author Lin, Chia-Chi


Jump to:
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Showing results 1 to 20 of 20
Issue DateTitleAuthor(s)SourcescopusWOSFulltext/Archive link
2015A randomized Phase 3 study comparing first-line pemetrexed plus cisplatin followed by gefitinib maintenance (PC/G) with gefitinib monotherapy (G) in East Asian patients (pts) with locally advanced or metastatic nonsquamous non-small cell lung cancer (nSqNSCLC): Final survival results.Yang, James Chih-Hsin; Srimuninnimit, Vichien; Ahn, Myung-Ju; Lin, Chia-Chi; Kim, Sang-We; Tsai, Chun-Ming; Mok, Tony; Orlando, Mauro; Puri, Tarun; Wang, Xin; Park, KeunchilJ. Clin. Oncol. 
2022B Cells in Tumor Microenvironment Associated With The Clinical Benefit to Programmed Cell Death Protein-1 Blockade Therapy in Patients With Advanced Esophageal Squamous Cell CarcinomaJHE-CYUAN GUO ; Hsu, Chia-Lang; YEN-LIN HUANG ; Lin, Chia-Chi; TA-CHEN HUANG ; Wu, I-Chen; Lin, Chen-Yuan; Lien, Ming-Yu; HUNG-YANG KUO ; ANN-LII CHENG ; CHIH-HUNG HSU Frontiers in oncology11
2014Bcl-2-Like Protein 11 Deletion Polymorphism Predicts Survival in Advanced Non-Small-Cell Lung CancerLee, Jih-Hsiang; Lin, Yu-Lin; Hsu, Wei-Hsun; Chen, Hsuan-Yu; Chang, Yeun-Chung; Yu, Chong-Jen; Shih, Jin-Yuan; Lin, Chia-Chi; Chen, Kuan-Yu; Ho, Chao-Chi; Laio, Wei-Yu; Yang, Pan-Chyr; Yang, James Chih-HsinJ. Thorac. Oncol.
2014Bcl-2-Like Protein 11 Deletion Polymorphism Predicts Survival in Advanced Non-Small-Cell Lung CancerLee, Jih-Hsiang; Lin, Yu-Lin; Hsu, Wei-Hsun; Chen, Hsuan-Yu; Chang, Yeun-Chung; Yu, Chong-Jen; Shih, Jin-Yuan; Lin, Chia-Chi; Chen, Kuan-Yu; Ho, Chao-Chi; Laio, Wei-Yu; Yang, Pan-Chyr; Yang, James Chih-Hsin; 楊泮池J. Thorac. Oncol. 
2022Clinical outcomes for patients with thymoma and thymic carcinoma after undergoing different front-line chemotherapy regimensWEI-LI MA ; Lin, Chia-Chi; FENG-MING HSU ; JANG-MING LEE ; JIN-SHING CHEN ; YEN-LIN HUANG ; YIH-LEONG CHANG ; Chang, Chin-Hao; CHIH-HSIN YANG Cancer medicine22
2022Deleterious alterations of DNA damage response and repair genes and clinical benefit to anti-PD-1 therapy in esophageal squamous cell carcinomaJHE-CYUAN GUO ; Lin, Chia-Chi; Hsu, Chia-Lang; TA-CHEN HUANG ; HUNG-YANG KUO ; Lin, Chen-Yuan; Lien, Ming-Yu; ANN-LII CHENG ; CHIH-HUNG HSU Esophagus : official journal of the Japan Esophageal Society00
2013EGFR inhibitors as the first-line systemic treatment for advanced non-small-cell lung cancerKao, Hsiang-Fong; Lin, Chia-Chi; Yang, James Chih-HsinFuture Oncology 76
2006Epidermal Growth Factor Receptor Inhibitor (Pd168393) Potentiates Cytotoxic Effects of Paclitaxel against Androgen-Independent Prostate Cancer CellsPU, YEONG-SHIAU; HSIEH, MIN-WEI; WANG, CHUANG-WEI; LIU, GUANG-YAW; HUANG, CHAO-YUAN; LIN, CHIA-CHI; GUAN, JING-YI; LIN, SHINNE- REN; HOUR, TZYH-CHYUAN; 蒲永孝; 謝旻娓; 王壯維; 劉光耀; 黃昭淵; 林家齊; 官靜儀; 林信仁; 侯自銓BIOCHEMICAL PHARMACOLOGY 
2006Epidermal growth factor receptor inhibitor (PD168393) potentiates cytotoxic effects of paclitaxel against androgen-independent prostate cancer cellsPu, Yeong-Shiau; Hsieh, Min-Wei; Wang, Chuang-Wei; Liu, Guang-Yaw; Huang, Chao-Yuan; Lin, Chia-Chi; Guan, Jing-Yi; Lin, Shinne-Ren; Hour, Tzyh-ChyuanBiochemical Pharmacology 
2015Epidermal growth factor receptor tyrosine kinase inhibitors on clinical outcome of advanced non-small cell lung cancer patients with leptomeningeal carcinomatosis.Liao, Bin-Chi; Lee, Jih-hsiang; Lin, Chia-Chi; Ho, Chao-Chi; Shih, Jin-Yuan; Yu, Chong-Jen; Yang, James Chih-HsinJ. Clin. Oncol. 
2015Epidermal growth factor receptor tyrosine kinase inhibitors on clinical outcome of advanced non-small cell lung cancer patients with leptomeningeal carcinomatosis.Liao, Bin-Chi; Lee, Jih-hsiang; Lin, Chia-Chi; Ho, Chao-Chi; Shih, Jin-Yuan; Yu, Chong-Jen; Yang, James Chih-HsinJ. Clin. Oncol.
2015Ipilimumab in treating Asian patient with advanced melanoma: The preliminary report of Taiwan ipilimumab extended access program groupWu, Chun-Feng; Huang, Wen Kuan; Liu, Jun-Huang; Lin, Chen-Yuan; Liu, Ta-Chih; Lin, Chia-Chi; Su, Wu-Chou; Yeh, Yumin; Cheng, Shih-Tsung; Lin, Sheng-Fung; Hong, Ruey-Long; Chang, John W. C.J. Clin. Oncol. 
2007Phase II Trial of Weekly Paclitaxel, Cisplatin Plus Infusional High-Dose 5-Fluorouracil and Leucovorin (TP-HDFL) for Metastatic Urothelial CarcinomaLin, Chia-Chi; Hsu, Chih-HungJournal of Urology 
2015Postchemoradiotherapy (CRT) pathologic stage classified by American Joint Committee on Cancer (AJCC) staging system to predict prognosis of patients with locally advanced esophageal squamous cell carcinoma (ESCC)Guo, Jhe-Cyuan; Huang, Ta-Chen; Lin, Chia-Chi; Hsieh, Min-Shu; Chang, Chin-Hao; Lee, Jang-Ming; Cheng, Jason C.; Wang, Hsiu-Po; Yeh, Kun-Huei; Cheng, Ann-Lii; Hsu, Chih-Hung; 鄭安理Journal of Clinical Oncology 00
2016The recurrence patterns and post-recurrence survivals in patients with locally advanced esophageal squamous cell carcinoma (ESCC) treated with preoperative paclitaxel/cisplatin-based chemoradiotherapy.Kuo, Hung-Yang; Guo, Jhe-Cyuan; Huang, Ta-Chen; Lin, Chia-Chi; Hsieh, Min-Shu; Lee, Jang-Ming; Cheng, Jason C.; Wang, Hsiu-Po; Yeh, Kun-Huei; Hsu, Chih-Hung; 成佳憲Journal of Clinical Oncology 00
2006Weekly Cisplatin Plus Infusional High-Dose 5-Fluorouracil and Leucovorin (P-HDFL) for Metastatic Urothelial Carcinoma --- An Effective Regimen with Low ToxicityLin, Chia-Chi; Hsu, Chih-Hung; Huang, Chao-Yuan; Cheng, Ann-Lii; Chen, Jun; Vogelzang, Nicholas J.; Pu, Yeong-ShiauCancer 
2007Weekly paclitaxel and high-dose 5-Fluorouracil plus leucovorin (T-HDFL) in hormone-refractory prostate cancer: in Vitro combined effects and phase II trialLin, Chia-Chi; Hsu, Chih-Hung; Hour, Tzyh-Chyuan; Cheng, Ann-Lii; Huang, Chao-Yuan; Huang, Kuo-How; Chen, Jun; Pu, Yeong-ShiauUROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS 
2008Zebrafish cdx1b regulates expression of downstream factors of Nodal signaling during early endoderm formationCheng, Pei-Yi; Lin, Chia-Chi; Wu, Chun-Shiu; Lu, Yu-Fen; Lin, Che Yi; Chung, Chih-Ching; Chu, Cheng-Ying; Huang, Chang-Jen; Tsai, Chun-Yen; Korzh, Svetlana; Wu, Jen-Leih; Hwang, Sheng-Ping L.Development 2524
2015探討度冬大杓鷸族群在彰化灘地之分布林家琪; Lin, Chia-Chi
2006泌尿上皮細胞癌全身性化學治療之研究林家齊; Lin, Chia-Chi
Showing results 1 to 20 of 20

臺大位居世界頂尖大學之列,為永久珍藏及向國際展現本校豐碩的研究成果及學術能量,圖書館整合機構典藏(NTUR)與學術庫(AH)不同功能平台,成為臺大學術典藏NTU scholars。期能整合研究能量、促進交流合作、保存學術產出、推廣研究成果。

To permanently archive and promote researcher profiles and scholarly works, Library integrates the services of “NTU Repository” with “Academic Hub” to form NTU Scholars.

總館學科館員 (Main Library)
醫學圖書館學科館員 (Medical Library)
社會科學院辜振甫紀念圖書館學科館員 (Social Sciences Library)

開放取用是從使用者角度提升資訊取用性的社會運動,應用在學術研究上是透過將研究著作公開供使用者自由取閱,以促進學術傳播及因應期刊訂購費用逐年攀升。同時可加速研究發展、提升研究影響力,NTU Scholars即為本校的開放取用典藏(OA Archive)平台。(點選深入了解OA)

  • 請確認所上傳的全文是原創的內容,若該文件包含部分內容的版權非匯入者所有,或由第三方贊助與合作完成,請確認該版權所有者及第三方同意提供此授權。
    Please represent that the submission is your original work, and that you have the right to grant the rights to upload.
  • 若欲上傳已出版的全文電子檔,可使用Sherpa Romeo網站查詢,以確認出版單位之版權政策。
    Please use Sherpa Romeo to find a summary of permissions that are normally given as part of each publisher's copyright transfer agreement.
  • 網站簡介 (Quickstart Guide)
  • 使用手冊 (Instruction Manual)
  • 線上預約服務 (Booking Service)
  • 方案一:臺灣大學計算機中心帳號登入
    (With C&INC Email Account)
  • 方案二:ORCID帳號登入 (With ORCID)
  • 方案一:定期更新ORCID者,以ID匯入 (Search for identifier (ORCID))
  • 方案二:自行建檔 (Default mode Submission)
  • 方案三:學科館員協助匯入 (Email worklist to subject librarians)
Build with DSpace-CRIS - Extension maintained and optimized by Logo 4SCIENCE Feedback